Fenfluramine Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 2.2 mg/mL, 5 mg/mL
Reference Brands: Fintepla (USA, EU)
Category: Neurology
Fenfluramine hydrochloride is an antiepileptic medication used for the treatment of seizures associated with Dravet syndrome and Lennox–Gastaut syndrome in patients aged two years and older. It works by modulating serotonergic activity in the brain, helping reduce the frequency and severity of seizures. Fintepla is available as an oral solution in 2.2 mg/mL and 5 mg/mL strengths, with dosing customized to patient needs under strict monitoring programs. Fenfluramine hydrochloride is available in Oral Solution and strengths such as 2.2 mg/mL, 5 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fenfluramine hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fenfluramine hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fenfluramine hydrochloride is used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients two years of age and older. It helps reduce the frequency and severity of seizures when used in combination with other antiepileptic medications. Previously, fenfluramine was used as an appetite suppressant, but its use for weight loss was discontinued due to cardiac side effects.
Fenfluramine hydrochloride is made from the active ingredient fenfluramine hydrochloride, a serotonin-releasing agent that also modulates sigma-1 receptors in the brain, helping to stabilize neuronal activity and reduce seizure episodes. Its chemical name is (±)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine hydrochloride. Inactive ingredients may vary depending on the formulation and manufacturer.
The trade name of fenfluramine hydrochloride is Fintepla.
Fenfluramine hydrochloride (Fintepla) is manufactured and marketed by UCB Pharma (formerly by Zogenix Inc., which was acquired by UCB).
The generic name of the drug is fenfluramine hydrochloride.
The brand name of fenfluramine hydrochloride is Fintepla.
Fenfluramine hydrochloride is manufactured in Europe and the United States by UCB Pharma and its licensed facilities. It is also distributed in other regions under regulatory approval for epilepsy treatment.
Related Products
Donepezil Hydrochloride
Strength:
5 mg, 10 mg, 23 mg
Form: Tablets
Reference Brands: Aricept (USA/EU)
View Details
Acetazolamide Sodium
Strength:
125 mg, 250 mg, 500 mg,
Form: Tablets/ capsules/ Injectable
Reference Brands: Diamox (USA)
View Details
Rimegepant
Strength:
75 mg
Form: Tablets
Reference Brands: Nurtec ODT (USA), Vydura (EU)
View Details
Pimavanserin
Strength:
17 mg, 34 mg, 51 mg
Form: Tablets
Reference Brands: Nuplazid (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
